What Researchers Did
Researchers conducted a literature review to discuss new perspectives on the conservative management of osteoradionecrosis of the mandible.
What They Found
They found that no standard treatment has been defined for osteoradionecrosis of the mandible, with various therapeutic options considered over decades. The clear clinical effectiveness of hyperbaric oxygen therapy varies, and the triplet tocopherol/pentoxifylline/clodronate requires more evidence from randomized clinical trials due to long treatment duration and potential side effects.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis of the mandible may face challenges in treatment selection due to the lack of a defined standard therapy. Discussions with their healthcare providers about the varying effectiveness and potential side effects of available conservative treatments are crucial.
Canadian Relevance
This study has no direct Canadian connection as it is a literature review without specific geographic patient data.
Study Limitations
A key limitation highlighted is the persistent lack of rigorous randomized prospective trials to establish a standard and effective conservative treatment for osteoradionecrosis of the mandible.